Stay updated with breaking news from Antibodies Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Evotec SE / Key word(s): Annual ResultsEvotec SE preliminary fiscal year 2022 results: 'Ahead of the curve' – very strong performance in a challenging year 28.03.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement. 22% INCREASE IN GROUP REVENUES; EBITDA EXCLUD...
EQS-News: EVOTEC SE / Key word(s): Annual Results Evotec SE preliminary fiscal year 2022 results: 'Ahead of the curve' very strong p...
EQS-News: Evotec SE / Key word(s): MiscellaneousEvotec presents paradigm shift in biologics at Capital Markets Day 02.11.2022 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement. TOGETHER FOR MEDICINES THAT MATTER: A PARADIGM SHIFT TO UNLOCK NEW MARKETS AND OPPORTUNITIES FOR G...
HAMBURG (dpa-AFX) - German drug maker Evotec SE (EVTCY.PK, EVOTF.PK) announced Tuesday that its Seattle-based unit, Just - Evotec Biologics, Inc., has received a contract from the U.S. Department
20.09.2022 - JUST - EVOTEC BIOLOGICS WILL SUPPORT THE DOD WITH RAPID, COST-EFFICIENT DEVELOPMENT OF SAFE, EFFICACIOUS ANTI-PLAGUE MABSEVOTEC WILL PROVIDE PRE-CLINICAL AND CLINICAL TRIAL SERVICESHAMBURG, GERMANT / ACCESSWIRE / September 20, 2022 / Evotec SE ... Seite 1